Symbol
| SEMA5A
| contributors: mct/npt - updated : 22-01-2014
|
HGNC name
| sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
|
HGNC id
| 10736
|
corresponding disease(s)
|
CDCS
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
in autism | |
Susceptibility
|
to Parkinson disease (PD) |
Variant & Polymorphism
other
| AC haplotype was associated with a significant increased risk of PD and the AT haplotype showed an associated decreased risk of PD |
|
|
Candidate gene
| in the etiology of idiopathic autism |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | brain | glioma/neuroblstoma | |
SEMA5A and PLXNB3 represent potential novel targets in counteracting glioma progression |
| | |
| Sema5A deficient mice display a defective branching of cranial vasculature, supporting its participation in blood vessel formation |